Walleye Trading
SNDX icon

Walleye Trading’s Syndax Pharmaceuticals SNDX Stock Holding History

Walleye Trading’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,500
Closed -$58.4K – 4423
2026
Q1 		$58.4K Sell
2,500
-4,900
-66% -$106K ﹤0.01% 3644
2025
Q4 		$155K Sell
7,400
-4,300
-37% -$75K ﹤0.01% 3518
2025
Q3 		$180K Sell
11,700
-3,200
-21% -$41.9K ﹤0.01% 3415
2025
Q2 		$140K Buy
+14,900
New +$164K ﹤0.01% 3439
2023
Q3 		– Sell
-800
Closed -$16.7K – 5332
2023
Q2 		$16.7K Buy
+800
New +$16.7K ﹤0.01% 4162
2022
Q1 		– Sell
-100
Closed -$2K – 5878
2021
Q4 		$2K Sell
100
-1,300
-93% -$24K ﹤0.01% 5252
2021
Q3 		$27K Buy
+1,400
New +$23.3K ﹤0.01% 4797

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Walleye Trading's SNDX Position: Q2 2026 in Review

Walleye Trading sold out of Syndax Pharmaceuticals (SNDX) in Q2 2026, closing a stake of 416 shares — an estimated $9.72K sold.

Walleye Trading first reported a position in SNDX in Q1 2019 and held it in 8 quarters. The position peaked at $2.44M in Q4 2021. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Walleye Trading reported no remaining Syndax Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 416 Syndax Pharmaceuticals shares in Q2 2026, an estimated $9.72K.
  • Walleye Trading first reported a position in Syndax Pharmaceuticals in Q1 2019 and held it in 8 quarters.
  • Walleye Trading's Syndax Pharmaceuticals position peaked at $2.44M in Q4 2021.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.